Ad
related to: average prognosis of leukemia
Search results
Results from the WOW.Com Content Network
The average five-year survival rate is 65% in the United States. [4] ... prevalence, diagnosis, treatment, and prognosis of leukemia is being performed.
Men are more commonly affected than women, although the average lifetime risk for both genders are similar (around 0.5-1%) . [17] [19] It is much less common in people from Asia. [4] Five-year survival following diagnosis is approximately 83% in the United States. [3] It represents less than 1% of deaths from cancer. [7]
Type Age adjusted mortality rates per 100,000 people, 2013-2017. [1]All Cancer: 158.3 Oral cancer: 0.0 Esophageal cancer: 3.9 Stomach cancer: 3.1 Colorectal cancer
Survival rates for most childhood cancers have improved, with a notable improvement in acute lymphoblastic leukemia (the most common childhood cancer). Due to improved treatment, the 5-year survival rate for acute lymphoblastic leukemia has increased from less than 10% in the 1960s to about 90% during the time period 2003-2009.
This means that a little over 10% of all newly diagnosed leukemia cases will be chronic myeloid leukemia. The average risk of a person getting this disease is 1 in 588. The disease is more common in men than women, and more common in whites than African-Americans. The average age at diagnosis is 64 years, and this disease is rarely seen in ...
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1] Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. [1]
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. [1] Symptoms may include feeling tired, pale skin color, fever , easy bleeding or bruising, enlarged lymph nodes , or bone pain. [ 1 ]
Five-year survival rates can be used to compare the effectiveness of treatments. Use of five-year survival statistics is more useful in aggressive diseases that have a shorter life expectancy following diagnosis, such as lung cancer, and less useful in cases with a long life expectancy, such as prostate cancer.
Ad
related to: average prognosis of leukemia